Literature DB >> 17667577

Nerve conduction blockade in the sciatic nerve prevents but does not reverse the activation of p38 mitogen-activated protein kinase in spinal microglia in the rat spared nerve injury model.

Yeong-Ray Wen1, Marc R Suter, Yasuhiko Kawasaki, Jin Huang, Marie Pertin, Tatsuro Kohno, Charles B Berde, Isabelle Decosterd, Ru-Rong Ji.   

Abstract

BACKGROUND: Current evidence indicates that p38 mitogen-activated protein kinase activation in spinal microglia contributes to the development of neuropathic pain. However, how nerve injury activates p38 in spinal microglia is incompletely unknown. Nerve injury-induced ectopic spontaneous activity is essential for the generation of neuropathic pain. The authors examined whether peripheral neural activity is necessary for p38 activation in spinal microglia.
METHODS: To examine whether spinal microglia activation depends on peripheral activity in the rat spared nerve injury (SNI) model, the authors blocked conduction in the sciatic nerve before or 2 days after SNI. The block was produced by applying bupivacaine-loaded microspheres above the nerve injury site. The p38 activation was examined by p38 phosphorylation using a phosphorylated p38 antibody, and neuropathic pain-related behavior was evaluated before and after intrathecal infusion of a p38 inhibitor.
RESULTS: Three days after SNI, there was a marked p38 activation in the medial two thirds of the dorsal horn, where the injured tibial and peroneal nerves terminated and where isolectin B4 staining was lost. Phosphorylated p38 was only colocalized with the microglial surface marker OX-42, indicating a microglial localization of phosphorylated p38 in the SNI model. Bupivacaine microspheres produced persistent block (loss of sensory and motor function) of the sciatic nerve for the whole period of the study (3 days). This blockade prevented but did not reverse p38 activation in spinal microglia. Intrathecal infusion of the p38 inhibitor FR167653 prevented and reversed mechanical allodynia on post-SNI day 3.
CONCLUSIONS: After nerve injury, activity in the peripheral nerve is required for the induction but not the maintenance of p38 activation in spinal microglia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17667577     DOI: 10.1097/01.anes.0000270759.11086.e7

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  55 in total

Review 1.  Microglia in Pain: Detrimental and Protective Roles in Pathogenesis and Resolution of Pain.

Authors:  Gang Chen; Yu-Qiu Zhang; Yawar J Qadri; Charles N Serhan; Ru-Rong Ji
Journal:  Neuron       Date:  2018-12-19       Impact factor: 17.173

Review 2.  Roles of TRESK, a novel two-pore domain K+ channel, in pain pathway and general anesthesia.

Authors:  Dong-Yue Huang; Bu-Wei Yu; Qiu-Wei Fan
Journal:  Neurosci Bull       Date:  2008-06       Impact factor: 5.203

Review 3.  p38(MAPK): stress responses from molecular mechanisms to therapeutics.

Authors:  Lydia R Coulthard; Danielle E White; Dominic L Jones; Michael F McDermott; Susan A Burchill
Journal:  Trends Mol Med       Date:  2009-08-06       Impact factor: 11.951

4.  Electroacupuncture attenuates spinal nerve ligation-induced microglial activation mediated by p38 mitogen-activated protein kinase.

Authors:  Yi Liang; Jun-Ying Du; Yu-Jie Qiu; Jun-Fan Fang; Jin Liu; Jian-Qiao Fang
Journal:  Chin J Integr Med       Date:  2015-04-06       Impact factor: 1.978

5.  A3 adenosine receptor agonist attenuates neuropathic pain by suppressing activation of microglia and convergence of nociceptive inputs in the spinal dorsal horn.

Authors:  Ryuji Terayama; Mitsuyasu Tabata; Kotaro Maruhama; Seiji Iida
Journal:  Exp Brain Res       Date:  2018-09-11       Impact factor: 1.972

6.  Activated microglia contribute to convergent nociceptive inputs to spinal dorsal horn neurons and the development of neuropathic pain.

Authors:  Yuya Yamamoto; Ryuji Terayama; Noriko Kishimoto; Kotaro Maruhama; Masahide Mizutani; Seiji Iida; Tomosada Sugimoto
Journal:  Neurochem Res       Date:  2015-03-18       Impact factor: 3.996

Review 7.  Pathological pain and the neuroimmune interface.

Authors:  Peter M Grace; Mark R Hutchinson; Steven F Maier; Linda R Watkins
Journal:  Nat Rev Immunol       Date:  2014-02-28       Impact factor: 53.106

Review 8.  Neuron-glia crosstalk gets serious: role in pain hypersensitivity.

Authors:  Ke Ren; Ronald Dubner
Journal:  Curr Opin Anaesthesiol       Date:  2008-10       Impact factor: 2.706

9.  Spinal cord stimulation reduces mechanical hyperalgesia and glial cell activation in animals with neuropathic pain.

Authors:  Karina L Sato; Lisa M Johanek; Luciana S Sanada; Kathleen A Sluka
Journal:  Anesth Analg       Date:  2014-02       Impact factor: 5.108

10.  Large A-fiber activity is required for microglial proliferation and p38 MAPK activation in the spinal cord: different effects of resiniferatoxin and bupivacaine on spinal microglial changes after spared nerve injury.

Authors:  Marc R Suter; Temugin Berta; Yong-Jing Gao; Isabelle Decosterd; Ru-Rong Ji
Journal:  Mol Pain       Date:  2009-09-22       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.